by Impulse Dynamics | Nov 16, 2022 | Press Releases
Experience Continues to Show CCM Therapy Addresses Clinical Need in Treating Heart Failure MARLTON, N.J., November 16, 2022 (GLOBE NEWSWIRE) — Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart failure, announced...
by Impulse Dynamics | Jun 14, 2022 | News and Events, Press Releases
MARLTON, N.J., JUNE 14, 2022 (GLOBE NEWSWIRE) — Impulse Dynamics, a commercial-stage medical device company focused on delivering our CCMTM therapy to people with heart failure, announced that the first implants in Europe for the newly launched Optimizer® Smart Mini...
by Impulse Dynamics | May 23, 2022 | News and Events, Press Releases
Investigators Report Positive Findings From Feasibility Study of CCM in Heart FailureWith Preserved Ejection Fraction at the European Society of Cardiology Heart Failure 2022 Congress MADRID and MARLTON, N.J., May 23, 2022 (GLOBE NEWSWIRE) — Impulse Dynamics, a global...
by Impulse Dynamics | May 12, 2022 | News and Events, Press Releases
Financing To Support Commercial Acceleration of the Optimizer Smart Mini, Enrollment in the Landmark AIM HIGHer Clinical Trial, and Continued Development of a CCM-D Combination Device MARLTON, N.J., May 12, 2022 (GLOBE NEWSWIRE) — Impulse Dynamics, a global medical...
by Impulse Dynamics | May 10, 2022 | News and Events, Press Releases
Company Is Committed to Innovation for Patients Living With Heart Failure MARLTON, N.J., May 10, 2022 (GLOBE NEWSWIRE) — Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart failure (HF), is announcing today the first...
